Zentalis Pharmaceuticals
· investing news network
Source Summary
Zentalis is a clinical oncology innovator developing a treatment approach for ovarian cancer and multiple tumor types.Leveraging therapeutics development and biomarker expertise, Zentalis is advancing monotherapy and combination studies of its investigational first-in-class WEE1 inhibitor, azenosert...
Advertisement